W58P052220012
Cooperative Agreement
Overview
Grant Description
Covid-19 action. Addition of two biosafety level 1 (BSL1) fill/finish lines to Jubilant Hollisterstier LLC, Spokane, WA facility.
Awardee
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Spokane,
Washington
992075788
United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the End Date has been shortened from 05/26/35 to 04/23/23 and the total obligations have decreased 77% from $149,684,100 to $34,373,105.
Jubilant Hollisterstier was awarded
COVID-19 Action: BSL1 Fill/Finish Lines for Pharma Manufacturing
Cooperative Agreement W58P052220012
worth $34,373,105
from Joint PEO for Chemical, Biological, Radiological and Nuclear Defense in May 2022 with work to be completed primarily in Spokane Washington United States.
The grant
has a duration of 1 year and
was awarded through assistance program 12.360 Research on Chemical and Biological Defense.
Status
(Complete)
Last Modified 7/11/23
Period of Performance
5/27/22
Start Date
4/23/23
End Date
Funding Split
$34.4M
Federal Obligation
$0.0
Non-Federal Obligation
$34.4M
Total Obligated
Activity Timeline
Transaction History
Modifications to W58P052220012
Additional Detail
Award ID FAIN
W58P052220012
SAI Number
None
Award ID URI
None
Awardee Classifications
For-Profit Organization (Other Than Small Business)
Other
Other
Awarding Office
W58P05 W6QK ACC-APG NATICK
Funding Office
W56XNH W6DZ JPMO CBD JPMO MCS (06)
Awardee UEI
LAKNZJ2KJG78
Awardee CAGE
1MN09
Performance District
05
Senators
Maria Cantwell
Patty Murray
Patty Murray
Representative
Cathy McMorris Rodgers
Modified: 7/11/23